<--- Back to Details
First PageDocument Content
Food and Drug Administration / Pharmaceutical industry / Clinical research / Savient pharmaceuticals / Pegloticase / PEGylation / Prescription Drug User Fee Act / Validation / Clinical trial
Date: 2016-07-11 16:59:30
Food and Drug Administration
Pharmaceutical industry
Clinical research
Savient pharmaceuticals
Pegloticase
PEGylation
Prescription Drug User Fee Act
Validation
Clinical trial

Microsoft Word - Savient Receives Complete Response from FDAdoc

Add to Reading List

Source URL: www.mvpharm.com

Download Document from Source Website

File Size: 28,05 KB

Share Document on Facebook

Similar Documents